ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Internal Medicine

Top Internal Medicine Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LUCAS CASUL MD

Internal Medicine

24,279

$30

392
360 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

29%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$0
Average prescription price

Avg: $59

MARK WESSELMAN MD

Internal Medicine

22,982

$907

372
342 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$0
Average prescription price

Avg: $59

G. MICHAEL LOPEZ M.D.

Internal Medicine

19,734

$1.28M

834
648 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $59

FERNANDO PARDO-RUIZ M.D.

Internal Medicine

16,600

$15.7K

370
346 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$1
Average prescription price

Avg: $59

AZHAR ZAHIR

Internal Medicine

16,360

$903K

737
594 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $59

RICHARD MOORE MD

Internal Medicine

16,313

$632K

829
692 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $59

SAMBAIAH KANKANALA MD

Internal Medicine

15,945

$934K

796
692 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $59

GAUDENCIO PAVIA M.D.

Internal Medicine

14,539

$879K

690
587 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $59

JORGE SEDAS MD

Internal Medicine

14,345

$874K

699
591 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $59

TRAVIS FISHER MD

Internal Medicine

14,223

$764K

692
527 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $59

NOOSHIN BAGHERI MD

Internal Medicine

13,722

$672K

697
546 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $59

COLICIA MEYEROWITZ MD

Internal Medicine

13,593

$850K

575
494 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $59

CHARLES BENTON MD

Internal Medicine

12,939

$604K

737
585 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $59

ROBIN TUCHLER MD

Internal Medicine

12,860

$696K

748
653 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $59

JAMES RUSSO DO

Internal Medicine

12,370

$788K

746
624 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $59

RUSSELL SCHULTZ MD

Internal Medicine

12,331

$816K

1113
1034 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $59

WALTER ROBINSON MD

Internal Medicine

12,176

$800K

650
540 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $59

DAVID HARDWICKE MD

Internal Medicine

11,915

$836K

731
610 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $59

BAYA OMIDNIA

Internal Medicine

11,669

$692K

438
377 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $59

HUNG QUAN MD

Internal Medicine

11,538

$525K

801
693 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $59

KATHY FINCH M.D.

Internal Medicine

11,527

$706K

599
505 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $59

FERIAL ABOOD MD

Internal Medicine

11,432

$864K

462
353 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $59

LAURA DAVENPORT-REED MD

Internal Medicine

11,286

$784K

308
270 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $59

PHILIP JAMESON MD

Internal Medicine

11,271

$697K

950
863 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $59

CLARE CASTIGLIA DO

Internal Medicine

11,058

$594K

738
657 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank